Spleen cell populations depleted of both B and T lymphocytes produce interleukin 4 (IL-4) in response to stimulation with immunoglobulins bound to the surface of culture dishes. In the presence of interleukin 3 (IL-3), platebound (PB) IgE and PB-IgG1, IgG2a, and IgG2b are excellent stimulants, whereas PB-IgA and PB-IgM fail to stimulate production. In the absence of IL-3, PB-IgE stimulates relatively modest production of IL-4, whereas PB-IgG2a generally does not. The response to PB-IgE is inhibited by soluble IgE; antibody to Fcy receptor II inhibits the response to PB-IgG2a.
Interactions between immunocompetent cells are largely mediated by the action of a set of polypeptide factors, designated lymphokines (LK) , that control the activation, growth, and differentiation of cells of the immune system and of related cell populations (1) . LK production by T lymphocytes is particularly important in regulating the functions of all cells that participate in immune responses. Recent evidence suggests that other hematopoietic lineage cells may also be important producers of "T-cell-derived" LKs. Many transformed murine mast cell lines express mRNA for and secrete one of these LK, interleukin 4 (IL-4) (2). Some lines also express mRNA for interleukin 3 (IL-3) and granulocyte/ macrophage colony-stimulating factor.
The demonstration that the IL-3-dependent myeloid cell line FDC/1 produces IL-3 and IL-4 upon exposure to immune complexes indicated the potential importance of Fc receptors in stimulating LK production by hematopoietic cells other than T cells (3) . We (4) and others (5) subsequently showed that long-term, IL-3-dependent mast cell lines produced IL-3, IL-4, interleukin , and interleukin 6 (IL-6), but not interleukin 2 (IL-2), interferon y (IFN-y) or lymphotoxin in response to calcium ionophores or to cross-linkage of their high-affinity FcE receptors. Cross-linkage of FcE receptors on mast cell lines has also been reported to lead to the release of other polypeptides, including interleukin 1 (IL-1) and several of the macrophage inflammatory proteins (6) .
These results raised the possibility that normal mast cells and other nonlymphoid hematopoietic lineage cells might participate in immune responses by production of LKs. In this report, we show that a cell population lacking B-and T-cell markers, in the spleen of normal mice, produces IL-4 when stimulated by cross-linkage of receptors for Fc portions of IgE or IgG subclasses. IL-3 greatly enhances (for IgE) or is required (for IgG) for IL-4 production by non-B, non-T cells from naive mice. This production of IL-4 in response to Fc receptor cross-linkage could be an important mechanism in immunologic inflammation in allergic diseases, in infections with helminthic parasites, as well as in diseases marked by accumulation of immune complexes.
MATERIALS AND METHODS
Animals. Virus-free BALB/c female mice, 8-12 weeks of age, were obtained from the Division of Cancer Therapy Animal Program, National Cancer Institute.
Preparation of Non-B, Non-T Cells, B Cells, and T Cells. Erythrocyte-depleted spleen cells were incubated at 4°C for 1 hr with a mixture of purified (7) fluoresceinated (F1) antibodies containing anti-Thy-1.2 (30H12) (8), anti-CD3 (2C11) (9), anti-CD4 (Gkl.5) (10), anti-CD8 (2.43) (11), anti-B220 (6B2) (12) , and anti-Iad (MKD6) (13) at 10 ,g/ml to yield non-B, non-T cells. B cells were prepared by incubating the spleen cells with anti-T-cell reagents (anti-Thy-1.2, anti-CD3, anti-CD4, and anti-CD8); T cells were prepared by incubating the spleen cells with the anti-B-cell reagents (anti-B220 and anti-Iad). At the end of the incubation, the cells were washed twice in staining buffer and mixed for 1 hr at 4°C with a suspension of magnetic beads coated with sheep anti-F1 antibodies (Advanced Magnetics, Cambridge, MA) (12 ml per 108 stained cells). Positively staining cells were depleted by two 20-min cycles of exposure to a magnetic field. The remaining cells were washed twice in culture medium and examined for the removal of the desired cell populations (B, T, or both B and T cells) by cytometric analysis on a FACScan (Becton Dickinson). The non-B, non-T-cell population contained <10% stained cells.
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line (14) , utilizing a standard that had initially been calibrated on the basis of 10 units/ml being equal to the amount of IL-4 required for half-maximal stimulation of [3H]thymidine uptake by resting B cells stimulated with 5 ug of goat anti-IgM antibody per ml (15, 16 (20, 000 cells per well) from mice that had been injected with anti-IgD 5 days earlier were cultured in the presence of IL-3 (50 units/ml) on plates that had been coated with each of the indicated mouse immunoglobulins, in the form of myeloma proteins at 10 ,g/ml, as described. IL-4 production was measured as described in the legend to Fig. 1. equal stimulatory capacity, whereas IgG3 stimulated smaller, but definite responses (Fig. 3) . PB-IgM and PB-IgA failed to stimulate IL-4 production. PB-IgE was an excellent stimulant.
IL-4 production by non-B, non-T cells from antiIgD-injected mice in response to PB-IgE is blocked by soluble IgE; 50% inhibition is obtained with <1 ,ug/ml (Fig.  4) . Soluble IgE has only a marginal inhibitory effect on the response to PB-IgG2a, even at 1 mg/ml. The rat monoclonal antibody 2.4G2, specific for Fcy receptor II (FcyRII) (22) Non-B, non-T cells were prepared from spleens of untreated and anti-IgD-injected mice. Cells were cultured in wells (25,000 cells per well) coated with IgE (10 ,ug/ml) with or without IL-3 (50 units/ml).
Supernatant fluids were harvested at 48 hr, and lymphokine assays were done as outlined. ND, not determined.
indicates a need for multivalent binding to signal IL-4 production.
Neither IL-2 nor IFN-y Are Produced by Non-B, Non-T Cells Stimulated by PB Immunoglobulins. We tested supernatants of non-B, non-T cells stimulated with PB-IgE for IL-2, IL-3, IL-4, and IFN-y activity (Table 1) . Non-B, non-T cells from untreated mice produced no detectable IL-4 in the absence of IL-3 but produced substantial amounts in its presence. (Our failure to detect IL-4 in the supernatants of non-B, non-T cells from untreated mice stimulated with PB-IgE in the absence of IL-3, although we had detected IL-4 production by these cells using the CT.4S co-culture assay, appears due to the substantially greater sensitivity of the latter assay.) IL-3 was produced in small amounts by non-B, non-T cells from normal mice and in substantial amounts by non-B, non-T cells from anti-IgD-injected mice. We have not yet tested the effect of IL-3 upon IL-3 production in these cells because of the protocol used in these experiments. Neither IL-2 nor IFN-y were detected in supernatants of non-B, non-T cells from normal mice or anti-IgD-injected mice stimulated with PB-IgE in the absence or presence of IL-3.
Characterization of Non-B, Non-T Cells That Produce IL-4 in Response to PB Immunoglobulins. To further characterize the splenic non-B, non-T cells that produce IL-4 in response to PB immunoglobulin, we prepared splenic non-B, non-T cells from untreated mice and from anti-IgD-injected mice and removed Macl+ cells by treatment with Fl-anti-Macl and depletion with anti-Fl conjugated magnetic beads. The Macldepleted populations and control non-B, non-T cells were equivalent in IL-4 production in response to PB-IgE and PB-IgG2a. We also subjected splenic non-B, non-T cells to density-gradient centrifugation in Percoll. The great majority of the IL-4-producing activity was found in the 50-60% Percoll band. The cells in this band were moderately large cells with basophilic cytoplasm, consistent with their being hematopoietic progenitor cells. Few mature polymorphonuclear leukocytes were observed in the band.
To test whether the non-B-, non-T-cell populations that produced IL-4 in response to PB immunoglobulins were natural killer (NK) cells, we depleted NK cell activity by treatment of mice with anti-asialo-GM1 antibodies (20) . Splenic non-B, non-T cells were prepared from these mice 1 day later. These cells were devoid of the capacity to lyse the NK-sensitive target cell YAC-1, indicating that NK activity had been depleted by this measure. Nonetheless, they showed enhanced IL-4 production in response to PB immunoglobulins, indicating that NK cells were not the major contributors to IL-4 production by non-B, non-T cells (Fig. 5) .
DISCUSSION
These studies indicate that IL-4, as well as IL-3, but not IL-2 and IFN-y, are produced by a spleen cell population that lacks T-cell (Thy-1, CD3, CD4 and CD8) and B-cell (B220, class II major histocompatibility complex) markers. LK production by such cells is stimulated by engagement of Fc receptors by PB immunoglobulins-most notably IgE and IgGl, IgG2a, and IgG2b. PB-IgM or IgA fail to stimulate these responses. Neither T cells nor B cells prepared from spleen produce IL-4 in response to PB immunoglobulins, making it highly unlikely that potentially contaminating T or B lymphocytes could be responsible for IL-4 production by non-B-, non-T-cell populations. NK cells have been reported to produce LKs, most notably IL-2 and IFN-y (23, 24) . However, we think it unlikely that NK cells are the major producers of IL-4 in response to PB immunoglobulins. (i) Many NK cells are Thy-1+ (25) . Such cells have been eliminated from our non-B, non-T-cell populations, and Thy-1+ cells (i.e., "T cells") fail to produce IL-4 in response to Fc receptor cross-linkage. (ii) Treatment of mice with antiasialo-GM1 completely depletes NK activity, as would be anticipated from the expression of asialo-GM1 on NK cell surfaces (20) . The remaining non-B, non-T-cell population is enriched in IL-4-producing capacity. (iii) The non-B-, non-T-cell population that we have examined fails to produce IL-2 and IFN-,y, which are the LKs known to be made by NK cells (23, 24) . These arguments do not rule out the possibility that NK cells can respond to PB immunoglobulins with IL-4 production. They do establish that other cells in the non-B-, non-T-cell population are excellent producers of The current work shows that the capacity of non-B, non-T cells to produce IL-4 depends upon, or is enhanced by, an IL-3-mediated event. Thus, normal non-B, non-T cells fail to produce (26, 27) . We interpret these findings to indicate that the capacity of non-B, non-T cells to secrete IL-4 ( and presumably IL-3) is regulated by the in vivo action of T lymphocytes, presumably through the production of IL-3.
There (32) , and such cells are good candidates for the PB-IgE-stimulated IL-4-producing cells in the non-B-, non-T-cell population.
The demonstration that non-B, non-T cells from immunized animals are a rich source of IL-4 and related LKs and that cells from untreated mice can be stimulated to produce IL-4 by treatment with PB immunoglobulins and IL-3 provides strong support for the concept that physiologic production of "T-cell-derived" LKs is not limited to T cells but may, under the influence of T cells, be a property of cells of several hematopoietic lineages. Further, these results suggest that non-B, non-T cells may be potential sources of LKs in disorders marked by the presence of immune complexes as well as in allergies and nematode infections. Indeed, persistence of immune complexes in certain depots may lead to chronic production of LKs and resultant local exacerbation of cellular inflammatory responses. The recent report that tumor cell lines expressing IL-4 as a result of transfection fail to grow in nude mice and that IL-4-producing tumors inhibit the growth of other transplantable tumors injected at the same site suggests that IL-4 may have an important role in control ofgrowth of malignant cells (33) . Activation of non-B, non-T cells by immune complexes could provide a mechanism through which antibody may participate in anti-tumor responses by eliciting local IL-4 production.
